• 検索結果がありません。

Girdin, a regulator of cell motility, is a potential prognostic marker for esophageal squamous cell carcinoma<Abstract of dissertation>

N/A
N/A
Protected

Academic year: 2021

シェア "Girdin, a regulator of cell motility, is a potential prognostic marker for esophageal squamous cell carcinoma<Abstract of dissertation>"

Copied!
2
0
0

読み込み中.... (全文を見る)

全文

(1)

Nagoya City University Academic Repository

学 位 の 種 類 博 士 (医 学) 報 告 番 号 甲第1392号 学 位 記 番 号 第997号 氏 名 柴田 孝弥 授 与 年 月 日 平成 25 年 7 月 30 日 学位論文の題名

Girdin, a regulator of cell motility, is a potential prognostic marker for esophageal squamous cell carcinoma

(細胞の移動の調節因子である Girdin は食道扁平上皮癌の予後マーカー となりうる)

ONCOLOGY REPORTS Vol.29: 2127-2132, 2013

論文審査担当者 主査: 稲垣 宏

(2)

Girdin, an actin-binding Akt substrate, regulates actin reconstruction and Akt-dependent cell migration in fibroblasts and a human breast cancer cell line. We examined whether Girdin was also involved in the migration of esophageal squamous cell carcinoma (ESCC) cells. First, immunofluorescent staining and migration assays were performed, using KYSE cell lines, to examine whether Girdin was involved in the migration of ESCC cells. Upon EGF stimulation, Girdin colocalized with filamentous actin in the lamellipodia as determined by immunofluorescent staining. In migration assays, cell migration was significantly reduced in KYSE cell lines transfected with Girdin siRNA compared with the negative control. Next, we examined the relationship between Girdin expression and clinical data, using specimens resected from ESCC patients. In immunohistochemical analyses using specimens resected from ESCC patients, overall survival was significantly longer in cases showing higher Girdin expression than in cases with lower Girdin expression. Taken together, it appears that Girdin is involved in the migration of ESCC cells. The level of Girdin expression correlated inversely with the survival of ESCC patients. Therefore, in ESCC, Girdin is expected to be a prognostic marker and to be a therapeutic target, as well.

参照

関連したドキュメント

As it is involved in cell growth, IER3 expression has been examined in several human tumors, including pancreatic carcinoma, ovarian carcinoma, breast cancer, and

Treatment with CH11 caused a relocalization of the 681 antigen: signals were no longer detectable in the cell nucleus, and instead cell bodies, in particular the region near

It is shown that plasma endothelial lipase (EL) activity inversely correlated with HDL-C levels, and EL activity in CAD patients was significantly higher than in non CAD

Pim-3, a proto-oncogene with serine ⁄ threonine kinase activity, is aberrantly expressed in human pancreatic cancer and phosphorylates Bad to block Bad-mediated apoptosis in

The objectives of this study were to evaluate the formation of lymphvascular niches in lymph nodes of patients with oral squamous cell carcinoma (OSCC), and investigate the roles

Met expression in A2058 melanoma cells was relatively heterogeneous, and a re- analysis of Met-low and Met-high cells after cell sorting indicated that Met-low and Met-high

 In conclusion, IFN-α alternation therapy is one treatment option for mRCC patients in whom first- line IFN-α treatment failed if the patient has only lung or

Neovastat (AE-941) in refractory renal cell carcinoma patients: report of a phase II trial with two dose levels. Phase I/II trial of the safety and efficacy of shark cartilage in